Repligen Corp (NASDAQ: RGEN) is 13.14% higher on its value in year-to-date trading and has touched a low of $113.50 and a high of $211.13 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RGEN stock was last observed hovering at around $157.29 in the last trading session, with the day’s gains setting it 5.56%.
Currently trading at $162.85, the stock is 8.09% and 10.36% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.91 million and changing 3.53% at the moment leaves the stock 10.07% off its SMA200. RGEN registered -5.74% loss for a year compared to 6-month gain of 23.08%. The firm has a 50-day simple moving average (SMA 50) of $147.5652 and a 200-day simple moving average (SMA200) of $147.95515.
The stock witnessed a 4.12% loss in the last 1 month and extending the period to 3 months gives it a 12.33%, and is 5.27% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.65% over the week and 4.49% over the month.
Repligen Corp (RGEN) has around 1783 employees, a market worth around $9.12B and $633.51M in sales. Fwd P/E is 93.36. Profit margin for the company is -1.28%. Distance from 52-week low is 43.48% and -22.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.30%).
with sales reaching $167.54M over the same period.The EPS is expected to shrink by -11.96% this year, but quarterly earnings will post -0.75% year-over-year. Quarterly sales are estimated to grow 7.58% in year-over-year returns.
620.0 institutions hold shares in Repligen Corp (RGEN), with institutional investors hold 109.56% of the company’s shares. The shares outstanding are 56.03M, and float is at 52.12M with Short Float at 6.08%. Institutions hold 102.35% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.57 million shares valued at $954.08 million. The investor’s holdings represent 13.5432 of the RGEN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.07 million shares valued at $638.67 million to account for 9.0659 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 4.61 million shares representing 8.2464 and valued at over $580.94 million, while STATE STREET CORP holds 3.109 of the shares totaling 1.74 million with a market value of $219.02 million.
Repligen Corp (RGEN) Insider Activity
The most recent transaction is an insider sale by Hunt Anthony, the company’s Director. SEC filings show that Hunt Anthony sold 24,246 shares of the company’s common stock on Nov 21 ’24 at a price of $139.67 per share for a total of $3.39 million. Following the sale, the insider now owns 0.14 million shares.
Still, SEC filings show that on Sep 10 ’24, Hunt Anthony (Director) disposed off 22,191 shares at an average price of $145.37 for $3.23 million. The insider now directly holds 139,840 shares of Repligen Corp (RGEN).
